Immunohistochemistry revealed that ObR, CD68, and IL-8 were significantly higher in invasive breast carcinoma tissue specimens than in benign and carcinoma in situ tissue specimens (P < 0.05, Figure 5). This evidence concerns the gene CD68 and invasive breast carcinoma.